TGFB1 and Hepatic fibrosis: Nevertheless, although in liver fibrosis, targeting of the pathways mediated by TGF-β, PDGF, Wnt/β-catenin and inflammatory factors are possible therapeutic strategies, their downregulation has been shown effective against the disease in various studies (Figure 4).